How often do you monitor urine protein levels for patients with membranous nephropathy for whom you initiate obinutuzumab?

When do you expect to first see an improvement?

Answer from: at Community Practice

Most studies of obinutuzumab in membranous nephropathy are retrospective, with remission rates of up to 83%. Would monitor UPCR every 1-3 months and check PLA2R every 3 months. Immunological remission (negative PLA2R) precedes clinical remission (one study with 76% at 3 mo and 80% at 6 mo), and clin...

Answer from: at Community Practice

Mother treatment for remembrance GN is very important, and monitoring your protein as well as PLA2R are extremely important as well.

Please select the option that best describes you:

How often do you monitor urine protein levels for patients with membranous nephropathy for whom you initiate obinutuzumab?

Related Questions